Moreover, elevated levels of IGF1 and insulin can activate phosphatidylinositol-3-kinase (PI3K)/AKT/mTOR and Ras/Mitogen-activated protein kinase (MAPK) pathways that are involved in HCC pathogenesis [94]. This evidence concerns the gene IGF1 and hepatocellular carcinoma.